loading...| Preferred Name |
Prazosin Hydrochloride |
|
| Synonyms |
|
|
| Definitions |
A synthetic piperazine derivative with hypotensive antiadrenergic properties, Prazosin Hydrochloride reduces peripheral resistance and relaxes vascular smooth muscles as a selective adrenergic alpha-1 antagonist by a mechanism not completely known. It is used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C1507 |
|
| CAS_Registry |
19237-84-4 |
|
| CHEBI_ID |
CHEBI:8365 |
|
| Chemical_Formula |
C19H21N5O4.HCl |
|
| code |
C1507 |
|
| Contributing_Source |
FDA |
|
| definition |
A synthetic piperazine derivative with hypotensive antiadrenergic properties, Prazosin Hydrochloride reduces peripheral resistance and relaxes vascular smooth muscles as a selective adrenergic alpha-1 antagonist by a mechanism not completely known. It is used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention. (NCI04) |
|
| FDA_UNII_Code |
X0Z7454B90 |
|
| Has_Free_Acid_Or_Base_Form | ||
| in_subset | ||
| label |
Prazosin Hydrochloride |
|
| Legacy Concept Name |
Prazosin_Hydrochloride |
|
| NSC Number |
292810 |
|
| Preferred_Name |
Prazosin Hydrochloride |
|
| prefixIRI |
NCIT:C1507 |
|
| prefLabel |
Prazosin Hydrochloride |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0700578 |
|
| subClassOf |